Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 8
2005 6
2006 3
2007 2
2008 3
2009 3
2010 6
2011 7
2012 5
2013 7
2014 12
2015 7
2016 5
2017 5
2018 10
2019 10
2020 8
2021 5
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
New sensitive tools to characterize meta-metabolome response to short- and long-term cobalt exposure in dynamic river biofilm communities.
Colas S, Marie B, Morin S, Milhe-Poutingon M, Foucault P, Chalvin S, Gelber C, Baldoni-Andrey P, Gurieff N, Fortin C, Le Faucheur S. Colas S, et al. Among authors: fortin c. Sci Total Environ. 2024 Jun 1;927:171851. doi: 10.1016/j.scitotenv.2024.171851. Epub 2024 Mar 20. Sci Total Environ. 2024. PMID: 38518822 Free article.
Treatment of severe human mpox virus infection with tecovirimat: A case series.
Demir KK, Desjardins M, Fortin C, Grandjean-Lapierre S, Chakravarti A, Coutlée F, Zaharatos G, Morin J, Tremblay C, Longtin J. Demir KK, et al. Among authors: fortin c. Can Commun Dis Rep. 2023 Feb 1;49(2-3):76-80. eCollection 2023 Feb 1. Can Commun Dis Rep. 2023. PMID: 38090723 Free PMC article.
Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel.
Dibernardo A, Toledo NP, Robinson A, Osiowy C, Giles E, Day J, Robbin Lindsay L, Drebot MA, Booth TF, Pidduck T, Baily A, Charlton CL, Tipples G, Kanji JN, Brochu G, Lang A, Therrien C, Bélanger-Collard M, Beaulac SN, Gilfix BM, Boivin G, Hamelin MÈ, Carbonneau J, Lévesque S, Martin P, Finzi A, Gendron-Lepage G, Goyette G, Benlarbi M, Gasser R, Fortin C, Martel-Lafferrière V, Lavoie M, Guérin R, Haraoui LP, Renaud C, Jenkins C, O'Brien SF, Drews SJ, Conrod V, Tran V, Awrey B, Scheuermann R, DuPuis A, Payne A, Warszycki C, Girardin R, Lee W, Zahariadis G, Jiao L, Needle R, Cordenbach J, Zaharatos J, Taylor K, Teltscher M, Miller M, Elsherif M, Robertson P, Robinson JL. Dibernardo A, et al. Among authors: fortin c. J Assoc Med Microbiol Infect Dis Can. 2022 Sep 27;7(3):186-195. doi: 10.3138/jammi-2021-0026. eCollection 2022 Sep. J Assoc Med Microbiol Infect Dis Can. 2022. PMID: 36337598 Free PMC article.
Covid-19 vaccine immunogenicity in people living with HIV-1.
Nault L, Marchitto L, Goyette G, Tremblay-Sher D, Fortin C, Martel-Laferrière V, Trottier B, Richard J, Durand M, Kaufmann D, Finzi A, Tremblay C. Nault L, et al. Among authors: fortin c. Vaccine. 2022 Jun 9;40(26):3633-3637. doi: 10.1016/j.vaccine.2022.04.090. Epub 2022 May 5. Vaccine. 2022. PMID: 35568588 Free PMC article.
114 results